{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:12:09Z","timestamp":1790435529945,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.annder.2016.09.035","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T14:17:33Z","timestamp":1476886653000},"page":"92-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Couverture vaccinale avant et apr\u00e8s instauration d\u2019un traitement immunosuppresseur (y compris bioth\u00e9rapie) pour psoriasis"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6554-5146","authenticated-orcid":false,"given":"A.","family":"Bonhomme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fr\u00e9ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Reigneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Poreaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Valois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Truchetet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barbaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Schmutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2016.09.035_bib0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0399-077X(09)74269-6","article-title":"COL2-04\u00a0risque d\u2019infections opportunistes (IO) sous traitement par anti-TNF\u03b1\u00a0: r\u00e9sultats finaux des 3\u00a0ans de surveillance de l\u2019observatoire RATIO","volume":"39","author":"Nicolas","year":"2009","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.annder.2016.09.035_bib0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.rhum.2013.08.004","article-title":"Conseils d\u2019utilisation des traitements anti-TNF et recommandations nationales de bonne pratique labellis\u00e9es par la Haute Autorit\u00e9 de sant\u00e9 fran\u00e7aise","volume":"80","author":"Go\u00ebb","year":"2013","journal-title":"Rev Rhum"},{"key":"10.1016\/j.annder.2016.09.035_bib0145","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaad.2013.06.046","article-title":"From the Medical Board of the National Psoriasis Foundation: vaccination in adult patients on systemic therapy for psoriasis","volume":"69","author":"Wine-Lee","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2016.09.035_bib0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4081\/reumatismo.2012.299","article-title":"Incidence of influenza-like illness into a cohort of patients affected by chronic inflammatory rheumatism and treated with biological agents","volume":"64","author":"Bello","year":"2012","journal-title":"Reumatismo"},{"key":"10.1016\/j.annder.2016.09.035_bib0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2474-8-58","article-title":"An audit of influenza and pneumococcal vaccination in rheumatology outpatients","volume":"8","author":"Sowden","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.annder.2016.09.035_bib0160","first-page":"208","article-title":"Influenza and pneumococcal vaccination and varicella status in inflammatory arthritis patients","volume":"104","author":"McCarthy","year":"2011","journal-title":"Ir Med J"},{"key":"10.1016\/j.annder.2016.09.035_bib0165","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaad.2007.08.030","article-title":"From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis","volume":"58","author":"Lebwohl","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2016.09.035_bib0170","unstructured":"Club rhumatismes et inflammations. Traitement anti-TNF alpha et suivi de la tol\u00e9rance. Conduite \u00e0 tenir en cas de vaccination. Rapport 2015. Disponible sur http:\/\/www.cri-net.com\/recherche\/fichesPratiques\/Anti-TNF_Dec2010\/F22_ANTI-TNF_VDEF.pdf."},{"key":"10.1016\/j.annder.2016.09.035_bib0175","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"Van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2016.09.035_bib0180","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.annder.2016.09.035_bib0185","unstructured":"Haut Conseil de la Sant\u00e9 publique. Vaccination des personnes immunod\u00e9prim\u00e9es ou aspl\u00e9niques. Recommandations. Rapport 2014. Disponible sur http:\/\/www.hcsp.fr\/explore.cgi\/avisrapportsdomaine?clefr=322."},{"key":"10.1016\/j.annder.2016.09.035_bib0190","first-page":"837","article-title":"Influenza vaccination rate among patients with moderate to severe psoriasis","volume":"11","author":"Radtke","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.annder.2016.09.035_bib0195","unstructured":"Institut de veille sanitaire. Couverture vaccinale. Donn\u00e9es 2015. Disponible sur http:\/\/www.invs.sante.fr\/Dossiers-thematiques\/Maladies-infectieuses\/Maladies-a-prevention-vaccinale\/Couverture-vaccinale\/Donnees\/Grippe."},{"key":"10.1016\/j.annder.2016.09.035_bib0200","first-page":"21","author":"Guthmann","year":"2011"},{"key":"10.1016\/j.annder.2016.09.035_bib0205","first-page":"63","article-title":"Yellow fever vaccine used in a psoriatic arthritis patient treated with methotrexate: a case report","volume":"23","author":"Stuhec","year":"2014","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.annder.2016.09.035_bib0210","unstructured":"Calendrier des vaccinations et recommandations vaccinales 2016. Rapport mars 2016. Disponible sur\u00a0: http:\/\/social-sante.gouv.fr\/IMG\/pdf\/calendrier_vaccinal_2016.pdf."},{"key":"10.1016\/j.annder.2016.09.035_bib0215","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2008.10.002","article-title":"Development of primary varicella infection during infliximab treatment for psoriasis","volume":"60","author":"Balato","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2016.09.035_bib0220","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000149311","article-title":"Recurrent varicella in an adult psoriasis patient treated with etanercept","volume":"217","author":"Becart","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2016.09.035_bib0225","first-page":"271","article-title":"Varicella zoster virus encephalitis during treatment with anti-tumor necrosis factor-\u03b1 agent in a psoriatic arthritis patient","volume":"33","author":"Buccoliero","year":"2010","journal-title":"New Microbiol"},{"key":"10.1016\/j.annder.2016.09.035_bib0230","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1365-4632.2006.02779.x","article-title":"An atypical varicella exanthem associated with the use of infliximab","volume":"45","author":"Choi","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2016.09.035_bib0235","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1468-3083.2006.01984.x","article-title":"Development of varicella during adalimumab theray","volume":"21","author":"Lee","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2016.09.035_bib0240","first-page":"2517","article-title":"Disseminated primary varicella infection during infliximab treatment","volume":"31","author":"Vonkeman","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2016.09.035_bib0245","first-page":"175","article-title":"Varicella Pneumonia in a woman receiving methotrexate for Psoriatic arthritis","volume":"16","author":"Helviz","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.annder.2016.09.035_bib0250","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0166-3542(91)90065-Y","article-title":"Effects of tumor necrosis factor alpha on replication of varicella-zoster virus","volume":"15","author":"Ito","year":"1991","journal-title":"Antiviral Res"},{"key":"10.1016\/j.annder.2016.09.035_bib0255","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ibd.23027","article-title":"Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD","volume":"19","author":"Naganuma","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.annder.2016.09.035_bib0130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaad.2013.08.049","article-title":"From the Medical Board of the National Psoriasis Foundation: recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis","volume":"70","author":"Motaparthi","year":"2014","journal-title":"J Am Acad Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963816304203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963816304203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:05:10Z","timestamp":1758971110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963816304203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0151963816304203"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2016.09.035","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Couverture vaccinale avant et apr\u00e8s instauration d\u2019un traitement immunosuppresseur (y compris bioth\u00e9rapie) pour psoriasis","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2016.09.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}